Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031845 · ClinicalTrials.gov registry record
Low-Dose Chest CT (LDCT) COVID-19 Study
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 121
- Enrollment target
NCT05031845 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 121 participants.
The verdict
NCT05031845 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
The goal of our proposed pilot study is to collect low dose CT (LDCT) findings from chest evaluations of a representative sample of 120 symptomatic Caucasian and African American, and Hispanic adults (45 each), stratified by presence of acute respiratory distress syndrome (ARDS) and COVID-19 positivity or negative PCR screening results. These data will provide us with preliminary data on the type and extent of alveolar remodeling by race and by severity of recent infectious respiratory disease. Findings from our study would will help us to determine if a larger multi-site research application to NHLBI or a similar funding agency might be possible and provide critical preliminary data on variation in LDCT findings by COVID-19 attributable respiratory health, race, and other risk factors (e.g., smoking history, comorbidities, and socioeconomic status).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2021-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05031845
The ClinicalTrials.gov registry entry for NCT05031845 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05031845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05031845 about?
NCT05031845 is a clinical study titled "Low-Dose Chest CT (LDCT) COVID-19 Study". The goal of our proposed pilot study is to collect low dose CT (LDCT) findings from chest evaluations of a representative sample of 120 symptomatic Caucasian and African American, and Hispanic adults (45 each), stratified by presence of acute respiratory distress syndrome (ARDS) and COVID-19 positiv...
What is the current status of trial NCT05031845?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2021-03-08. Estimated completion is 2021-12-30.
Who is sponsoring clinical trial NCT05031845?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.